Author:
Scagnolari Carolina,Duda Petra,Bagnato Francesca,Vito Gabriella,Alberelli Alessia,Lavolpe Vito,Girardi Enrico,Durastanti Valentina,Trojano Maria,Kappos Ludwig,Antonelli Guido
Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology,Neurology
Reference51 articles.
1. Markowitz C (2004) Development of interferon-beta as a therapy for multiple sclerosis. Expert Opin Emerg Drugs 9:363-74
2. Cohen JA, Cutter GR, Fischer JS, Goodman AD, Heidenreich FR, Kooijmans MF, Sandrock AW, Rudick RA, Simon JH, Simonian NA, Tsao EC, Whitaker JN; IMPACT Investigators (2002) Benefit of interferon beta-1a on MSFC progression in secondary progressive MS. Neurology 59:679-87
3. Kappos L, Weinshenker B, Pozzilli C, Thompson AJ, Dahlke F, Beckmann K, Polman C, McFarland H, European (EU-SPMS) Interferon beta-1b in Secondary Progressive Multiple Sclerosis Trial Steering Committee, Independent Advisory Board; North American (NASPMS) Interferon beta-1b in Secondary Progressive Multiple Sclerosis Trial Steering Committee and Independent Advisory Board (2004) Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials. Neurology 63:1779-787
4. Kivisakk P, Alm GV, Fredrikson S, Link H (2000) Neutralizing and binding anti-interferon-beta (IFN-beta) antibodies A comparison between IFN-beta- 1a and IFN-beta-1b treatment in multiple sclerosis. Eur J Neurol 7:27-4
5. Perini P, Facchinetti A, Bulian P, Massaro AR, Pascalis DD, Bertolotto A, Biasi G, Gallo P (2001) Interferon-beta (INF-beta) antibodies in interferon-beta1a- and interferon-beta1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivo. Eur Cytokine Netw 12:56-1
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献